Home > > > Report Detail

Global Cancer Monoclonal Antibodies Industry Research Report, Growth Trends and Competitive Analysis 2022-2028

Publisher Name :
Date: 16-Nov-2022
No. of pages: 84
Inquire Before Buying

Report Scope

This latest report researches the industry structure, sales, revenue, price and gross margin. Major producers' production locations, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Cancer Monoclonal Antibodies manufacturers, distributors, end users, industry associations, governments' industry bureaus, industry publications, industry experts, third party database, and our in-house databases.

This report also includes a discussion of the major players across each regional Cancer Monoclonal Antibodies market. Further, it explains the major drivers and regional dynamics of the global Cancer Monoclonal Antibodies market and current trends within the industry.

Key Companies Covered

In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and market share analysis of the prominent players are also provided in this section. Additionally, the specialists have done an all-encompassing analysis of each player. They have also provided reliable sales, revenue, price, market share and rank data of the manufacturers for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:

- F. Hoffmann-La Roche

- Amgen

- Bristol-Myers Squibb

- Takeda Pharmaceuticals

Market Segments

This report has explored the key segments: by Type and by Application. The lucrativeness and growth potential have been looked into by the industry experts in this report. This report also provides sales, revenue and average price forecast data by type and by application segments based on sales, price, and value for the period 2017-2028.

Cancer Monoclonal Antibodies Segment by Type

- Murine Antibodies

- Chimeric and Humanised Antibodies

- Fully Humanized Antibodies

- Others

Cancer Monoclonal Antibodies Segment by Application

- Liver

- Breast

- Blood

- Brain

- Hodgkins and Non-Hodgkins lymphoma

- Colorectal

- Leukaemia

- Others

Key Regions & Countries

This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the value and sales data of each region and country for the period 2017-2028.

- North America

- - U.S.

- - Canada

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - India

- - Australia

- - Taiwan

- - Indonesia

- - Thailand

- - Malaysia

- - Philippines

- - Vietnam

- Latin America

- - Mexico

- - Brazil

- - Argentina

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - U.A.E

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

COVID-19 and Russia-Ukraine War Influence Analysis

The readers in the section will understand how the Cancer Monoclonal Antibodies market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.

Report Includes:

This report presents an overview of global market for Cancer Monoclonal Antibodies, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2017 - 2021, estimates for 2022, and projections of CAGR through 2028.

This report researches the key producers of Cancer Monoclonal Antibodies, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Cancer Monoclonal Antibodies, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Cancer Monoclonal Antibodies sales, revenue, market share and industry ranking of main manufacturers, data from 2017 to 2022. Identification of the major stakeholders in the global Cancer Monoclonal Antibodies market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by type and by application, sales, revenue, and price, from 2017 to 2028. Evaluation and forecast the market size for Cancer Monoclonal Antibodies sales, projected growth trends, production technology, application and end-user industry.

Descriptive company profiles of the major global players, including F. Hoffmann-La Roche, Amgen, Bristol-Myers Squibb and Takeda Pharmaceuticals, etc.

Global Cancer Monoclonal Antibodies Industry Research Report, Growth Trends and Competitive Analysis 2022-2028

Table of Contents
1 Report Overview
1.1 Research Scope
1.2 Market Segment by Type
1.2.1 Global Cancer Monoclonal Antibodies Market Size Growth Rate by Type (2017 VS 2021 VS 2028)
1.2.2 Murine Antibodies
1.2.3 Chimeric and Humanised Antibodies
1.2.4 Fully Humanized Antibodies
1.2.5 Others
1.3 Market Segment by Application
1.3.1 Global Cancer Monoclonal Antibodies Market Share by Application (2017 VS 2021 VS 2028)
1.3.2 Liver
1.3.3 Breast
1.3.4 Blood
1.3.5 Brain
1.3.6 Hodgkins and Non-Hodgkins lymphoma
1.3.7 Colorectal
1.3.8 Leukaemia
1.3.9 Others
1.4 Study Objectives
1.5 Years Considered
2 Market Perspective
2.1 Global Cancer Monoclonal Antibodies Market Size (2017-2028)
2.1.1 Global Cancer Monoclonal Antibodies Revenue (2017-2028)
2.1.2 Global Cancer Monoclonal Antibodies Sales (2017-2028)
2.2 Global Cancer Monoclonal Antibodies Market Size across Key Geographies Worldwide: 2017 VS 2021 VS 2028
2.2.1 Global Cancer Monoclonal Antibodies Sales by Regions (2017-2022)
2.2.2 Global Cancer Monoclonal Antibodies Revenue by Regions (2017-2022)
2.3 Global Cancer Monoclonal Antibodies Market Size Forecast by Region
2.3.1 Global Cancer Monoclonal Antibodies Sales Forecast by Region (2023-2028)
2.3.2 Global Cancer Monoclonal Antibodies Revenue Forecast by Region (2023-2028)
2.4 Global Top Cancer Monoclonal Antibodies Regions (Countries) Ranking by Market Size
2.5 Cancer Monoclonal Antibodies Market Dynamics
2.5.1 Cancer Monoclonal Antibodies Market Trends
2.5.2 Cancer Monoclonal Antibodies Market Drivers
2.5.3 Cancer Monoclonal Antibodies Market Challenges
2.5.4 Cancer Monoclonal Antibodies Market Restraints
3 Competitive Landscape by Manufacturers
3.1 Global Top Cancer Monoclonal Antibodies Manufacturers by Sales (2017-2022)
3.1.1 Global Cancer Monoclonal Antibodies Sales by Manufacturers (2017-2022)
3.1.2 Global Cancer Monoclonal Antibodies Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global 5 and 10 Largest Manufacturers by Cancer Monoclonal Antibodies Sales in 2021
3.2 Global Top Manufacturers Cancer Monoclonal Antibodies by Revenue
3.2.1 Global Cancer Monoclonal Antibodies Revenue by Manufacturers (2017-2022)
3.2.2 Top Cancer Monoclonal Antibodies Manufacturers Covered: Ranking by Revenue
3.2.3 Global Cancer Monoclonal Antibodies Revenue Share by Manufacturers (2017-2022)
3.2.4 Global Cancer Monoclonal Antibodies Market Concentration Ratio (CR5 and HHI)
3.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Cancer Monoclonal Antibodies as of 2021)
3.4 Global Cancer Monoclonal Antibodies Average Selling Price (ASP) by Manufacturers
3.5 Key Manufacturers Cancer Monoclonal Antibodies Plants/Factories Distribution and Area Served
3.6 Date of Key Manufacturers Enter into Cancer Monoclonal Antibodies Market
3.7 Key Manufacturers Cancer Monoclonal Antibodies Product Offered
3.8 Mergers & Acquisitions, Expansion Plans
4 Global Cancer Monoclonal Antibodies Market Size by Type
4.1 Global Cancer Monoclonal Antibodies Historic Market Review by Type (2017-2022)
4.1.1 Global Cancer Monoclonal Antibodies Sales Market Share by Type (2017-2022)
4.1.2 Global Cancer Monoclonal Antibodies Revenue Market Share by Type (2017-2022)
4.1.3 Cancer Monoclonal Antibodies Price by Type (2017-2022)
4.2 Global Cancer Monoclonal Antibodies Market Estimates and Forecasts by Type (2023-2028)
4.2.1 Global Cancer Monoclonal Antibodies Sales Forecast by Type (2023-2028)
4.2.2 Global Cancer Monoclonal Antibodies Revenue Forecast by Type (2023-2028)
4.2.3 Cancer Monoclonal Antibodies Price Forecast by Type (2023-2028)
5 Global Cancer Monoclonal Antibodies Market Size by Application
5.1 Global Cancer Monoclonal Antibodies Historic Market Review by Application (2017-2022)
5.1.1 Global Cancer Monoclonal Antibodies Sales Market Share by Application (2017-2022)
5.1.2 Global Cancer Monoclonal Antibodies Revenue Market Share by Application (2017-2022)
5.1.3 Cancer Monoclonal Antibodies Price by Application (2017-2022)
5.2 Global Cancer Monoclonal Antibodies Market Estimates and Forecasts by Application (2023-2028)
5.2.1 Global Cancer Monoclonal Antibodies Sales Forecast by Application (2023-2028)
5.2.2 Global Cancer Monoclonal Antibodies Revenue Forecast by Application (2023-2028)
5.2.3 Cancer Monoclonal Antibodies Price Forecast by Application (2023-2028)
6 North America
6.1 North America Cancer Monoclonal Antibodies Sales Breakdown by Company
6.1.1 North America Cancer Monoclonal Antibodies Sales by Company (2017-2022)
6.1.2 North America Cancer Monoclonal Antibodies Revenue by Company (2017-2022)
6.2 North America Cancer Monoclonal Antibodies Market Size by Type
6.2.1 North America Cancer Monoclonal Antibodies Sales by Type (2017-2028)
6.2.2 North America Cancer Monoclonal Antibodies Revenue by Type (2017-2028)
6.3 North America Cancer Monoclonal Antibodies Market Size by Application
6.3.1 North America Cancer Monoclonal Antibodies Sales by Application (2017-2028)
6.3.2 North America Cancer Monoclonal Antibodies Revenue by Application (2017-2028)
6.4 North America Cancer Monoclonal Antibodies Market Size by Country
6.4.1 North America Cancer Monoclonal Antibodies Sales by Country (2017-2028)
6.4.2 North America Cancer Monoclonal Antibodies Revenue by Country (2017-2028)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe Cancer Monoclonal Antibodies Sales Breakdown by Company
7.1.1 Europe Cancer Monoclonal Antibodies Sales by Company (2017-2022)
7.1.2 Europe Cancer Monoclonal Antibodies Revenue by Company (2017-2022)
7.2 Europe Cancer Monoclonal Antibodies Market Size by Type
7.2.1 Europe Cancer Monoclonal Antibodies Sales by Type (2017-2028)
7.2.2 Europe Cancer Monoclonal Antibodies Revenue by Type (2017-2028)
7.3 Europe Cancer Monoclonal Antibodies Market Size by Application
7.3.1 Europe Cancer Monoclonal Antibodies Sales by Application (2017-2028)
7.3.2 Europe Cancer Monoclonal Antibodies Revenue by Application (2017-2028)
7.4 Europe Cancer Monoclonal Antibodies Market Size by Country
7.4.1 Europe Cancer Monoclonal Antibodies Sales by Country (2017-2028)
7.4.2 Europe Cancer Monoclonal Antibodies Revenue by Country (2017-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
8 Asia Pacific
8.1 Asia Pacific Cancer Monoclonal Antibodies Sales Breakdown by Company
8.1.1 Asia Pacific Cancer Monoclonal Antibodies Sales by Company (2017-2022)
8.1.2 Asia Pacific Cancer Monoclonal Antibodies Revenue by Company (2017-2022)
8.2 Asia Pacific Cancer Monoclonal Antibodies Market Size by Type
8.2.1 Asia Pacific Cancer Monoclonal Antibodies Sales by Type (2017-2028)
8.2.2 Asia Pacific Cancer Monoclonal Antibodies Revenue by Type (2017-2028)
8.3 Asia Pacific Cancer Monoclonal Antibodies Market Size by Application
8.3.1 Asia Pacific Cancer Monoclonal Antibodies Sales by Application (2017-2028)
8.3.2 Asia Pacific Cancer Monoclonal Antibodies Revenue by Application (2017-2028)
8.4 Asia Pacific Cancer Monoclonal Antibodies Market Size by Region
8.4.1 Asia Pacific Cancer Monoclonal Antibodies Sales by Region
8.4.2 Asia Pacific Cancer Monoclonal Antibodies Revenue by Region
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 India
8.4.7 Australia
8.4.8 Taiwan
8.4.9 Indonesia
8.4.10 Thailand
8.4.11 Malaysia
8.4.12 Philippines
8.4.13 Vietnam
9 Latin America
9.1 Latin America Cancer Monoclonal Antibodies Sales Breakdown by Company
9.1.1 Latin America Cancer Monoclonal Antibodies Sales by Company (2017-2022)
9.1.2 Latin America Cancer Monoclonal Antibodies Revenue by Company (2017-2022)
9.2 Latin America Cancer Monoclonal Antibodies Market Size by Type
9.2.1 Latin America Cancer Monoclonal Antibodies Sales by Type (2017-2028)
9.2.2 Latin America Cancer Monoclonal Antibodies Revenue by Type (2017-2028)
9.3 Latin America Cancer Monoclonal Antibodies Market Size by Application
9.3.1 Latin America Cancer Monoclonal Antibodies Sales by Application (2017-2028)
9.3.2 Latin America Cancer Monoclonal Antibodies Revenue by Application (2017-2028)
9.4 Latin America Cancer Monoclonal Antibodies Market Size by Country
9.4.1 Latin America Cancer Monoclonal Antibodies Sales by Country (2017-2028)
9.4.2 Latin America Cancer Monoclonal Antibodies Revenue by Country (2017-2028)
9.4.3 Mexico
9.4.4 Brazil
9.4.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Cancer Monoclonal Antibodies Sales Breakdown by Company
10.1.1 Middle East and Africa Cancer Monoclonal Antibodies Sales by Company (2017-2022)
10.1.2 Middle East and Africa Cancer Monoclonal Antibodies Revenue by Company (2017-2022)
10.2 Middle East and Africa Cancer Monoclonal Antibodies Market Size by Type
10.2.1 Middle East and Africa Cancer Monoclonal Antibodies Sales by Type (2017-2028)
10.2.2 Middle East and Africa Cancer Monoclonal Antibodies Revenue by Type (2017-2028)
10.3 Middle East and Africa Cancer Monoclonal Antibodies Market Size by Application
10.3.1 Middle East and Africa Cancer Monoclonal Antibodies Sales by Application (2017-2028)
10.3.2 Middle East and Africa Cancer Monoclonal Antibodies Revenue by Application (2017-2028)
10.4 Middle East and Africa Cancer Monoclonal Antibodies Market Size by Country
10.4.1 Middle East and Africa Cancer Monoclonal Antibodies Sales by Country (2017-2028)
10.4.2 Middle East and Africa Cancer Monoclonal Antibodies Revenue by Country (2017-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 U.A.E
11 Company Profiles
11.1 F. Hoffmann-La Roche
11.1.1 F. Hoffmann-La Roche Corporation Information
11.1.2 F. Hoffmann-La Roche Overview
11.1.3 F. Hoffmann-La Roche Cancer Monoclonal Antibodies Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.1.4 F. Hoffmann-La Roche Cancer Monoclonal Antibodies Products and Services
11.1.5 F. Hoffmann-La Roche Cancer Monoclonal Antibodies SWOT Analysis
11.1.6 F. Hoffmann-La Roche Recent Developments
11.2 Amgen
11.2.1 Amgen Corporation Information
11.2.2 Amgen Overview
11.2.3 Amgen Cancer Monoclonal Antibodies Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.2.4 Amgen Cancer Monoclonal Antibodies Products and Services
11.2.5 Amgen Cancer Monoclonal Antibodies SWOT Analysis
11.2.6 Amgen Recent Developments
11.3 Bristol-Myers Squibb
11.3.1 Bristol-Myers Squibb Corporation Information
11.3.2 Bristol-Myers Squibb Overview
11.3.3 Bristol-Myers Squibb Cancer Monoclonal Antibodies Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.3.4 Bristol-Myers Squibb Cancer Monoclonal Antibodies Products and Services
11.3.5 Bristol-Myers Squibb Cancer Monoclonal Antibodies SWOT Analysis
11.3.6 Bristol-Myers Squibb Recent Developments
11.4 Takeda Pharmaceuticals
11.4.1 Takeda Pharmaceuticals Corporation Information
11.4.2 Takeda Pharmaceuticals Overview
11.4.3 Takeda Pharmaceuticals Cancer Monoclonal Antibodies Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.4.4 Takeda Pharmaceuticals Cancer Monoclonal Antibodies Products and Services
11.4.5 Takeda Pharmaceuticals Cancer Monoclonal Antibodies SWOT Analysis
11.4.6 Takeda Pharmaceuticals Recent Developments
12 Value Chain and Sales Channels Analysis
12.1 Cancer Monoclonal Antibodies Value Chain Analysis
12.2 Cancer Monoclonal Antibodies Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Cancer Monoclonal Antibodies Production Mode & Process
12.4 Cancer Monoclonal Antibodies Sales and Marketing
12.4.1 Cancer Monoclonal Antibodies Sales Channels
12.4.2 Cancer Monoclonal Antibodies Distributors
12.5 Cancer Monoclonal Antibodies Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
List of Tables
Table 1. Global Cancer Monoclonal Antibodies Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Murine Antibodies
Table 3. Major Manufacturers of Chimeric and Humanised Antibodies
Table 4. Major Manufacturers of Fully Humanized Antibodies
Table 5. Major Manufacturers of Others
Table 6. Global Cancer Monoclonal Antibodies Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 7. Global Cancer Monoclonal Antibodies Market Size (US$ Million) by Region: 2017 VS 2021 VS 2028
Table 8. Global Cancer Monoclonal Antibodies Sales by Region (2017-2022) & (K Units)
Table 9. Global Cancer Monoclonal Antibodies Sales Market Share by Region (2017-2022)
Table 10. Global Cancer Monoclonal Antibodies Revenue by Region (2017-2022) & (US$ Million)
Table 11. Global Cancer Monoclonal Antibodies Revenue Market Share by Region (2017-2022)
Table 12. Global Cancer Monoclonal Antibodies Sales Forecast by Region (2023-2028) & (K Units)
Table 13. Global Cancer Monoclonal Antibodies Sales Market Share Forecast by Region (2023-2028)
Table 14. Global Cancer Monoclonal Antibodies Revenue Forecast by Region (2023-2028) & (US$ Million)
Table 15. Global Cancer Monoclonal Antibodies Revenue Market Share Forecast by Region (2023-2028)
Table 16. Top Cancer Monoclonal Antibodies Regions (Countries) Ranking by Market Size (US$ Million) in 2021
Table 17. Cancer Monoclonal Antibodies Market Trends
Table 18. Cancer Monoclonal Antibodies Market Drivers
Table 19. Cancer Monoclonal Antibodies Market Challenges
Table 20. Cancer Monoclonal Antibodies Market Restraints
Table 21. Global Cancer Monoclonal Antibodies Sales by Manufacturers (2017-2022) & (K Units)
Table 22. Global Cancer Monoclonal Antibodies Sales Share by Manufacturers (2017-2022)
Table 23. Global Cancer Monoclonal Antibodies Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 24. Ranking of Global Top Cancer Monoclonal Antibodies Manufacturers by Revenue (US$ Million) in 2021
Table 25. Cancer Monoclonal Antibodies Revenue Share by Manufacturers (2017-2022)
Table 26. Global Cancer Monoclonal Antibodies Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 27. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Cancer Monoclonal Antibodies as of 2021)
Table 28. Key Manufacturers Cancer Monoclonal Antibodies Average Selling Price (ASP) & (2017-2022) & (USD/Unit)
Table 29. Key Manufacturers Cancer Monoclonal Antibodies Plants/Factories Distribution
Table 30. Key Manufacturers Cancer Monoclonal Antibodies Area Served
Table 31. Date of Key Manufacturers Enter into Cancer Monoclonal Antibodies Market
Table 32. Key Manufacturers Cancer Monoclonal Antibodies Product Type
Table 33. Mergers & Acquisitions, Expansion Plans
Table 34. Global Cancer Monoclonal Antibodies Sales (K Units) by Type (2017-2022)
Table 35. Global Cancer Monoclonal Antibodies Sales Share by Type (2017-2022)
Table 36. Global Cancer Monoclonal Antibodies Revenue (US$ Million) Market Share by Type (2017-2022)
Table 37. Global Cancer Monoclonal Antibodies Price (K Units) by Type (2017-2022)
Table 38. Global Cancer Monoclonal Antibodies Sales (K Units) by Type (2023-2028)
Table 39. Global Cancer Monoclonal Antibodies Sales Share by Type (2023-2028)
Table 40. Global Cancer Monoclonal Antibodies Revenue (US$ Million) Market Share by Type (2023-2028)
Table 41. Global Cancer Monoclonal Antibodies Revenue Share by Type (2023-2028)
Table 42. Global Cancer Monoclonal Antibodies Price (K Units) by Type (2023-2028)
Table 43. Global Cancer Monoclonal Antibodies Sales (K Units) by Application (2017-2022)
Table 44. Global Cancer Monoclonal Antibodies Sales Share by Application (2017-2022)
Table 45. Global Cancer Monoclonal Antibodies Revenue (US$ Million) Market Share by Application (2017-2022)
Table 46. Global Cancer Monoclonal Antibodies Price (K Units) by Application (2017-2022)
Table 47. Global Cancer Monoclonal Antibodies Sales (K Units) by Application (2023-2028)
Table 48. Global Cancer Monoclonal Antibodies Sales Share by Application (2023-2028)
Table 49. Global Cancer Monoclonal Antibodies Revenue (US$ Million) Market Share by Application (2023-2028)
Table 50. Global Cancer Monoclonal Antibodies Revenue Share by Application (2023-2028)
Table 51. Global Cancer Monoclonal Antibodies Price (K Units) by Application (2023-2028)
Table 52. North America Cancer Monoclonal Antibodies Sales by Company (2017-2022) & (K Units)
Table 53. North America Cancer Monoclonal Antibodies Sales Market Share by Company (2017-2022)
Table 54. North America Cancer Monoclonal Antibodies Revenue by Company (2017-2022) & (US$ Million)
Table 55. North America Cancer Monoclonal Antibodies Revenue Market Share by Company (2017-2022)
Table 56. North America Cancer Monoclonal Antibodies Sales by Type (2017-2022) & (K Units)
Table 57. North America Cancer Monoclonal Antibodies Sales by Type (2023-2028) & (K Units)
Table 58. North America Cancer Monoclonal Antibodies Revenue by Type (2017-2022) & (US$ Million)
Table 59. North America Cancer Monoclonal Antibodies Revenue by Type (2023-2028) & (US$ Million)
Table 60. North America Cancer Monoclonal Antibodies Sales by Application (2017-2022) & (K Units)
Table 61. North America Cancer Monoclonal Antibodies Sales by Application (2023-2028) & (K Units)
Table 62. North America Cancer Monoclonal Antibodies Revenue by Application (2017-2022) & (US$ Million)
Table 63. North America Cancer Monoclonal Antibodies Revenue by Application (2023-2028) & (US$ Million)
Table 64. North America Cancer Monoclonal Antibodies Sales by Country (2017-2022) & (K Units)
Table 65. North America Cancer Monoclonal Antibodies Sales by Country (2023-2028) & (K Units)
Table 66. North America Cancer Monoclonal Antibodies Revenue by Country (2017-2022) & (US$ Million)
Table 67. North America Cancer Monoclonal Antibodies Revenue by Country (2023-2028) & (US$ Million)
Table 68. Europe Cancer Monoclonal Antibodies Sales by Company (2017-2022) & (K Units)
Table 69. Europe Cancer Monoclonal Antibodies Sales Market Share by Company (2017-2022)
Table 70. Europe Cancer Monoclonal Antibodies Revenue by Company (2017-2022) & (US$ Million)
Table 71. Europe Cancer Monoclonal Antibodies Revenue Market Share by Company (2017-2022)
Table 72. Europe Cancer Monoclonal Antibodies Sales by Type (2017-2022) & (K Units)
Table 73. Europe Cancer Monoclonal Antibodies Sales by Type (2023-2028) & (K Units)
Table 74. Europe Cancer Monoclonal Antibodies Revenue by Type (2017-2022) & (US$ Million)
Table 75. Europe Cancer Monoclonal Antibodies Revenue by Type (2023-2028) & (US$ Million)
Table 76. Europe Cancer Monoclonal Antibodies Sales by Application (2017-2022) & (K Units)
Table 77. Europe Cancer Monoclonal Antibodies Sales by Application (2023-2028) & (K Units)
Table 78. Europe Cancer Monoclonal Antibodies Revenue by Application (2017-2022) & (US$ Million)
Table 79. Europe Cancer Monoclonal Antibodies Revenue by Application (2023-2028) & (US$ Million)
Table 80. Europe Cancer Monoclonal Antibodies Sales by Country (2017-2022) & (K Units)
Table 81. Europe Cancer Monoclonal Antibodies Sales by Country (2023-2028) & (K Units)
Table 82. Europe Cancer Monoclonal Antibodies Revenue by Country (2017-2022) & (US$ Million)
Table 83. Europe Cancer Monoclonal Antibodies Revenue by Country (2023-2028) & (US$ Million)
Table 84. Asia Pacific Cancer Monoclonal Antibodies Sales by Company (2017-2022) & (K Units)
Table 85. Asia Pacific Cancer Monoclonal Antibodies Sales Market Share by Company (2017-2022)
Table 86. Asia Pacific Cancer Monoclonal Antibodies Revenue by Company (2017-2022) & (US$ Million)
Table 87. Asia Pacific Cancer Monoclonal Antibodies Revenue Market Share by Company (2017-2022)
Table 88. Asia Pacific Cancer Monoclonal Antibodies Sales by Type (2017-2022) & (K Units)
Table 89. Asia Pacific Cancer Monoclonal Antibodies Sales by Type (2023-2028) & (K Units)
Table 90. Asia Pacific Cancer Monoclonal Antibodies Revenue by Type (2017-2022) & (US$ Million)
Table 91. Asia Pacific Cancer Monoclonal Antibodies Revenue by Type (2023-2028) & (US$ Million)
Table 92. Asia Pacific Cancer Monoclonal Antibodies Sales by Application (2017-2022) & (K Units)
Table 93. Asia Pacific Cancer Monoclonal Antibodies Sales by Application (2023-2028) & (K Units)
Table 94. Asia Pacific Cancer Monoclonal Antibodies Revenue by Application (2017-2022) & (US$ Million)
Table 95. Asia Pacific Cancer Monoclonal Antibodies Revenue by Application (2023-2028) & (US$ Million)
Table 96. Asia Pacific Cancer Monoclonal Antibodies Sales by Region (2017-2022) & (K Units)
Table 97. Asia Pacific Cancer Monoclonal Antibodies Sales by Region (2023-2028) & (K Units)
Table 98. Asia Pacific Cancer Monoclonal Antibodies Revenue by Region (2017-2022) & (US$ Million)
Table 99. Asia Pacific Cancer Monoclonal Antibodies Revenue by Region (2023-2028) & (US$ Million)
Table 100. Latin America Cancer Monoclonal Antibodies Sales by Company (2017-2022) & (K Units)
Table 101. Latin America Cancer Monoclonal Antibodies Sales Market Share by Company (2017-2022)
Table 102. Latin America Cancer Monoclonal Antibodies Revenue by Company (2017-2022) & (US$ Million)
Table 103. Latin America Cancer Monoclonal Antibodies Revenue Market Share by Company (2017-2022)
Table 104. Latin America Cancer Monoclonal Antibodies Sales by Type (2017-2022) & (K Units)
Table 105. Latin America Cancer Monoclonal Antibodies Sales by Type (2023-2028) & (K Units)
Table 106. Latin America Cancer Monoclonal Antibodies Revenue by Type (2017-2022) & (US$ Million)
Table 107. Latin America Cancer Monoclonal Antibodies Revenue by Type (2023-2028) & (US$ Million)
Table 108. Latin America Cancer Monoclonal Antibodies Sales by Application (2017-2022) & (K Units)
Table 109. Latin America Cancer Monoclonal Antibodies Sales by Application (2023-2028) & (K Units)
Table 110. Latin America Cancer Monoclonal Antibodies Revenue by Application (2017-2022) & (US$ Million)
Table 111. Latin America Cancer Monoclonal Antibodies Revenue by Application (2023-2028) & (US$ Million)
Table 112. Latin America Cancer Monoclonal Antibodies Sales by Country (2017-2022) & (K Units)
Table 113. Latin America Cancer Monoclonal Antibodies Sales by Country (2023-2028) & (K Units)
Table 114. Latin America Cancer Monoclonal Antibodies Revenue by Country (2017-2022) & (US$ Million)
Table 115. Latin America Cancer Monoclonal Antibodies Revenue by Country (2023-2028) & (US$ Million)
Table 116. Middle East and Africa Cancer Monoclonal Antibodies Sales by Company (2017-2022) & (K Units)
Table 117. Middle East and Africa Cancer Monoclonal Antibodies Sales Market Share by Company (2017-2022)
Table 118. Middle East and Africa Cancer Monoclonal Antibodies Revenue by Company (2017-2022) & (US$ Million)
Table 119. Middle East and Africa Cancer Monoclonal Antibodies Revenue Market Share by Company (2017-2022)
Table 120. Middle East and Africa Cancer Monoclonal Antibodies Sales by Type (2017-2022) & (K Units)
Table 121. Middle East and Africa Cancer Monoclonal Antibodies Sales by Type (2023-2028) & (K Units)
Table 122. Middle East and Africa Cancer Monoclonal Antibodies Revenue by Type (2017-2022) & (US$ Million)
Table 123. Middle East and Africa Cancer Monoclonal Antibodies Revenue by Type (2023-2028) & (US$ Million)
Table 124. Middle East and Africa Cancer Monoclonal Antibodies Sales by Application (2017-2022) & (K Units)
Table 125. Middle East and Africa Cancer Monoclonal Antibodies Sales by Application (2023-2028) & (K Units)
Table 126. Middle East and Africa Cancer Monoclonal Antibodies Revenue by Application (2017-2022) & (US$ Million)
Table 127. Middle East and Africa Cancer Monoclonal Antibodies Revenue by Application (2023-2028) & (US$ Million)
Table 128. Middle East and Africa Cancer Monoclonal Antibodies Sales by Country (2017-2022) & (K Units)
Table 129. Middle East and Africa Cancer Monoclonal Antibodies Sales by Country (2023-2028) & (K Units)
Table 130. Middle East and Africa Cancer Monoclonal Antibodies Revenue by Country (2017-2022) & (US$ Million)
Table 131. Middle East and Africa Cancer Monoclonal Antibodies Revenue by Country (2023-2028) & (US$ Million)
Table 132. F. Hoffmann-La Roche Corporation Information
Table 133. F. Hoffmann-La Roche Description and Overview
Table 134. F. Hoffmann-La Roche Cancer Monoclonal Antibodies Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)
Table 135. F. Hoffmann-La Roche Cancer Monoclonal Antibodies Product and Services
Table 136. F. Hoffmann-La Roche Cancer Monoclonal Antibodies SWOT Analysis
Table 137. F. Hoffmann-La Roche Recent Developments
Table 138. Amgen Corporation Information
Table 139. Amgen Description and Overview
Table 140. Amgen Cancer Monoclonal Antibodies Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)
Table 141. Amgen Cancer Monoclonal Antibodies Product and Services
Table 142. Amgen Cancer Monoclonal Antibodies SWOT Analysis
Table 143. Amgen Recent Developments
Table 144. Bristol-Myers Squibb Corporation Information
Table 145. Bristol-Myers Squibb Description and Overview
Table 146. Bristol-Myers Squibb Cancer Monoclonal Antibodies Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)
Table 147. Bristol-Myers Squibb Cancer Monoclonal Antibodies Product and Services
Table 148. Bristol-Myers Squibb Cancer Monoclonal Antibodies SWOT Analysis
Table 149. Bristol-Myers Squibb Recent Developments
Table 150. Takeda Pharmaceuticals Corporation Information
Table 151. Takeda Pharmaceuticals Description and Overview
Table 152. Takeda Pharmaceuticals Cancer Monoclonal Antibodies Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)
Table 153. Takeda Pharmaceuticals Cancer Monoclonal Antibodies Product and Services
Table 154. Takeda Pharmaceuticals Cancer Monoclonal Antibodies SWOT Analysis
Table 155. Takeda Pharmaceuticals Recent Developments
Table 156. Key Raw Materials Lists
Table 157. Raw Materials Key Suppliers Lists
Table 158. Cancer Monoclonal Antibodies Distributors List
Table 159. Cancer Monoclonal Antibodies Customers List
Table 160. Research Programs/Design for This Report
Table 161. Key Data Information from Secondary Sources
Table 162. Key Data Information from Primary Sources
List of Figures
Figure 1. Cancer Monoclonal Antibodies Product Picture
Figure 2. Global Cancer Monoclonal Antibodies Sales Market Share by Type in 2021 & 2028
Figure 3. Murine Antibodies Product Picture
Figure 4. Chimeric and Humanised Antibodies Product Picture
Figure 5. Fully Humanized Antibodies Product Picture
Figure 6. Others Product Picture
Figure 7. Global Cancer Monoclonal Antibodies Sales Market Share by Application in 2021 & 2028
Figure 8. Liver Use Case
Figure 9. Breast Use Case
Figure 10. Blood Use Case
Figure 11. Brain Use Case
Figure 12. Hodgkins and Non-Hodgkins lymphoma Use Case
Figure 13. Colorectal Use Case
Figure 14. Leukaemia Use Case
Figure 15. Others Use Case
Figure 16. Cancer Monoclonal Antibodies Report Years Considered
Figure 17. Global Cancer Monoclonal Antibodies Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 18. Global Cancer Monoclonal Antibodies Market Size 2017-2028 (US$ Million)
Figure 19. Global Cancer Monoclonal Antibodies Sales (2017-2022) & (K Units)
Figure 20. Global Cancer Monoclonal Antibodies Market Size Market Share by Region: 2021 VS 2028
Figure 21. Global Cancer Monoclonal Antibodies Sales Market Share by Region (2017-2022)
Figure 22. Global Cancer Monoclonal Antibodies Sales Market Share by Region in 2021
Figure 23. Global Cancer Monoclonal Antibodies Revenue Market Share by Region in 2017 VS 2021
Figure 24. Global Cancer Monoclonal Antibodies Sales Share by Manufacturers in 2021
Figure 25. The 5 and 10 Largest Manufacturers in the World: Market Share by Cancer Monoclonal Antibodies Sales in 2021
Figure 26. Cancer Monoclonal Antibodies Revenue Share by Manufacturers in 2021
Figure 27. Cancer Monoclonal Antibodies Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
Figure 28. Global Cancer Monoclonal Antibodies Revenue Share by Type (2017-2022)
Figure 29. Global Cancer Monoclonal Antibodies Revenue Growth Rate by Type in 2017 & 2021
Figure 30. Global Cancer Monoclonal Antibodies Revenue Share by Application (2017-2022)
Figure 31. Global Cancer Monoclonal Antibodies Revenue Growth Rate by Application in 2017 & 2021
Figure 32. North America Cancer Monoclonal Antibodies Sales Market Share by Type (2017-2028)
Figure 33. North America Cancer Monoclonal Antibodies Revenue Market Share by Type (2017-2028)
Figure 34. North America Cancer Monoclonal Antibodies Sales Market Share by Application (2017-2028)
Figure 35. North America Cancer Monoclonal Antibodies Revenue Market Share by Application (2017-2028)
Figure 36. North America Cancer Monoclonal Antibodies Sales Share by Country (2017-2028)
Figure 37. North America Cancer Monoclonal Antibodies Revenue Share by Country (2017-2028)
Figure 38. U.S. Cancer Monoclonal Antibodies Revenue (2017-2028) & (US$ Million)
Figure 39. Canada Cancer Monoclonal Antibodies Revenue (2017-2028) & (US$ Million)
Figure 40. Europe Cancer Monoclonal Antibodies Sales Market Share by Type (2017-2028)
Figure 41. Europe Cancer Monoclonal Antibodies Revenue Market Share by Type (2017-2028)
Figure 42. Europe Cancer Monoclonal Antibodies Sales Market Share by Application (2017-2028)
Figure 43. Europe Cancer Monoclonal Antibodies Revenue Market Share by Application (2017-2028)
Figure 44. Europe Cancer Monoclonal Antibodies Sales Share by Country (2017-2028)
Figure 45. Europe Cancer Monoclonal Antibodies Revenue Share by Country (2017-2028)
Figure 46. Germany Cancer Monoclonal Antibodies Revenue (2017-2028) & (US$ Million)
Figure 47. France Cancer Monoclonal Antibodies Revenue (2017-2028) & (US$ Million)
Figure 48. U.K. Cancer Monoclonal Antibodies Revenue (2017-2028) & (US$ Million)
Figure 49. Italy Cancer Monoclonal Antibodies Revenue (2017-2028) & (US$ Million)
Figure 50. Russia Cancer Monoclonal Antibodies Revenue (2017-2028) & (US$ Million)
Figure 51. Asia Pacific Cancer Monoclonal Antibodies Sales Market Share by Type (2017-2028)
Figure 52. Asia Pacific Cancer Monoclonal Antibodies Revenue Market Share by Type (2017-2028)
Figure 53. Asia Pac
  • Global Botox for Hyperhidrosis Treatment Market Research Report 2023
    Published: 26-May-2023        Price: US 2900 Onwards        Pages: 91
    The global Botox for Hyperhidrosis Treatment market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes. North American market for Botox for Hyperhidrosis Treatment is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 throug......
  • Global Caffeine Citrate Injection Market Research Report 2023
    Published: 26-May-2023        Price: US 2900 Onwards        Pages: 91
    The global Caffeine Citrate Injection market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes. North American market for Caffeine Citrate Injection is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029. ......
  • Global Anti-aging Chinese Herbs Market Research Report 2023
    Published: 26-May-2023        Price: US 2900 Onwards        Pages: 101
    The global Anti-aging Chinese Herbs market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes. North American market for Anti-aging Chinese Herbs is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029. Asi......
  • Global Medical Nicotine Transdermal Skin Patch Market Research Report 2023
    Published: 26-May-2023        Price: US 2900 Onwards        Pages: 103
    The global Medical Nicotine Transdermal Skin Patch market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes. North American market for Medical Nicotine Transdermal Skin Patch is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of......
  • Global Genetically Modified Drug Market Research Report 2023
    Published: 26-May-2023        Price: US 2900 Onwards        Pages: 103
    Drugs made by genetically modified means are also called "biological drugs" The global Genetically Modified Drug market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes. North American market for Genetically Modified Drug is estimated to increase from $ million in 2023 to reach $ millio......
  • Global Cyclic Olefin Polymers Syringe Market Research Report 2023
    Published: 26-May-2023        Price: US 2900 Onwards        Pages: 93
    Cyclic olefin copolymer (COC) is an amorphous polymer made by several polymer manufacturers. COP (Cyclo-Olefin-Polymer) syringes are distinguished by a high degree of break resistance, glass-like transparency and very low oxygen permeation compared to other plastics. The global Cyclic Olefin Polymers Syringe market was valued at US$ 709 million in 2022 and is anticipated to reach US$ 1065.6 million by 2029, witnessing a CAGR of 6.0% during the forecast period 2023-2029. The influence of C......
  • Global Live and Attenuated Vaccine Market Research Report 2023
    Published: 26-May-2023        Price: US 2900 Onwards        Pages: 98
    The global Live and Attenuated Vaccine market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes. North American market for Live and Attenuated Vaccine is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.......
  • Global Peripherally Acting Anti-Obesity Drug Market Research Report 2023
    Published: 26-May-2023        Price: US 2900 Onwards        Pages: 91
    The global Peripherally Acting Anti-Obesity Drug market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes. North American market for Peripherally Acting Anti-Obesity Drug is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 202......
  • Global Medical Oral Medicine Market Research Report 2023
    Published: 26-May-2023        Price: US 2900 Onwards        Pages: 95
    Oral medical drugs mainly include drugs for treating infections in the oral cavity, throat, periodontal and other parts, and alleviating local pain and irritation in the oral cavity. The global Medical Oral Medicine market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes. North American......
    • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs